Reports on SOD1 levels in the CSF of ALS patients have been inconsistent; some studies detected increased levels (Kokić et al., 2005) whereas others have identified decreased levels (Ihara et al., 2005) or levels comparable to controls (Zetterström et al., 2011). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.